PMID- 30651975 OWN - NLM STAT- MEDLINE DCOM- 20200302 LR - 20200309 IS - 2047-2994 (Electronic) IS - 2047-2994 (Linking) VI - 8 DP - 2019 TI - HIV infection in Xi'an, China: epidemic characterization, risk factors to false positives and potential utility of the sample-to-cutoff index to identify true positives using Architect HIV Ag/Ab combo. PG - 9 LID - 10.1186/s13756-019-0463-0 [doi] LID - 9 AB - BACKGROUND: In China, although tremendous efforts has been made, the HIV/AIDS is still not controlled. OBJECTIVES: The study was carried out to determine the epidemic of HIV infection in Xi'an, analyse false positives (FP) risk factors and potential utility of sample-to-cutoff index to identify true positives using Architect HIV Ag/Ab Combo. METHODS: A retrospective review for HIV screening by Architect HIV Ag/Ab Combo was performed in a teaching hospital in Xi'an between 2015 and 2016. The prevalence of HIV, positive predictive value (PPV) at different cut-off indexices (COI) were calculated. The epidemic of infections and risk factors for FP results were investigated. RESULTS: In the study, the HIV prevalence and FP rate of Architect HIV Ag/Ab Combo were 0.076 and 46.08%, respectively. The Han Chinese, males and people aged < 40 years accounted for the majority of infections (98.29, 76.07 and 73.5%, respectively). 85.47% of the infections were transmitted through sexual contact (35.04% of male homosexual and 50.43% of heterosexual). COI at 1-10, 10-30 and >/= 30, the PPVs were 0, 50 and 100%, respectively. The independent risk factors for FP, i.e., pregnancy and malignancy had a statistically significant association with FP (p < 0.05), and age had a very strong statistically significant association with FP (p < 0.001). CONCLUSIONS: In Xi'an, sexual contact was the most important transmission mode for HIV, and the infections were predominantly identified in Han Chinese, males, young and middle-aged people. For Architect HIV Ag/Ab Combo, it can achieve 100% of PPV with COI >/=30, and the age was strongly statistically associated with FP. FAU - Wang, Linchuan AU - Wang L AD - 1Clinical Laboratory of the First Affiliated Hospital of Xi'an Jiaotong University, Yan Ta Road No 277, Xi'an, Shaanxi Province China. FAU - Xiao, Yao AU - Xiao Y AD - 1Clinical Laboratory of the First Affiliated Hospital of Xi'an Jiaotong University, Yan Ta Road No 277, Xi'an, Shaanxi Province China. FAU - Tian, Xu-Dong AU - Tian XD AD - 1Clinical Laboratory of the First Affiliated Hospital of Xi'an Jiaotong University, Yan Ta Road No 277, Xi'an, Shaanxi Province China. FAU - Ruan, Jin-Xiong AU - Ruan JX AD - 1Clinical Laboratory of the First Affiliated Hospital of Xi'an Jiaotong University, Yan Ta Road No 277, Xi'an, Shaanxi Province China. FAU - Chen, Wei AU - Chen W AD - 1Clinical Laboratory of the First Affiliated Hospital of Xi'an Jiaotong University, Yan Ta Road No 277, Xi'an, Shaanxi Province China. FAU - Yu, Yan AU - Yu Y AD - 2Inspection Department of Hong-Hui Hospital, Xi'an Jiaotong University College of Medicine, Nan Guo Road No 76, Xi'an, Shaanxi Province China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20190111 PL - England TA - Antimicrob Resist Infect Control JT - Antimicrobial resistance and infection control JID - 101585411 RN - 0 (HIV Antibodies) RN - 0 (HIV Antigens) SB - IM MH - Adolescent MH - Adult MH - Aged MH - Aged, 80 and over MH - Child MH - Child, Preschool MH - China/epidemiology/ethnology MH - False Positive Reactions MH - Female MH - HIV Antibodies/*blood MH - HIV Antigens/*blood MH - HIV Infections/blood/*diagnosis/epidemiology/ethnology MH - Humans MH - Male MH - Middle Aged MH - Retrospective Studies MH - Risk Factors MH - Serologic Tests MH - Young Adult PMC - PMC6329139 OTO - NOTNLM OT - Architect HIV ag/ab combo OT - False positives OT - HIV epidemic COIS- The study was deemed exempt from review by the Ethics Committee of the First Affiliated Hospital of Xi'an Jiaotong University as routine data for clinical purposes were used, and all patient information remained confidential in the study.LW, YX, XDT, JR, YY and WC have read and approved the final manuscript for publication in Antimicrobial Resistance & Infection Control.LW, YX, XDT, JR, YY and WC declare that they have no competing interest.Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. EDAT- 2019/01/18 06:00 MHDA- 2020/03/03 06:00 PMCR- 2019/01/11 CRDT- 2019/01/18 06:00 PHST- 2017/12/15 00:00 [received] PHST- 2019/01/03 00:00 [accepted] PHST- 2019/01/18 06:00 [entrez] PHST- 2019/01/18 06:00 [pubmed] PHST- 2020/03/03 06:00 [medline] PHST- 2019/01/11 00:00 [pmc-release] AID - 463 [pii] AID - 10.1186/s13756-019-0463-0 [doi] PST - epublish SO - Antimicrob Resist Infect Control. 2019 Jan 11;8:9. doi: 10.1186/s13756-019-0463-0. eCollection 2019.